B. V. van Eck

The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma

H. Caron, G. Tytgat, H. Heij, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.

H. Caron, H. V. van Santen, A. Verschuur, 2008, European journal of cancer.

High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during 131I‐meta‐iodobenzylguanidine treatment in children with neuroblastoma

H. V. van Santen, J. de Vijlder, B. V. van Eck, 2002, Cancer.

Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma

H. V. van Santen, J. de Vijlder, B. V. van Eck, 2003, Cancer.

Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of 99mTc-Hynic-rh-Annexin V Imaging

M. Verheij, C. Hoefnagel, R. Olmos, 2008, Clinical medicine. Oncology.

Toxicity of upfront 131I-metaiodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis

H. Caron, G. Tytgat, C. Hoefnagel, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Pulmonary embolism: validation of spiral CT angiography in 149 patients.

A. van Rossum, P. Pattynama, G. Kieft, 1996, Radiology.